Company Profile

Artemis Strategic Investment Corporation is a blank check company. The Company's business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company is focused on identifying a business combination target that provides technology to experiential entertainment within the gaming, hospitality and entertainment industries. It has no operations and has no revenues.

Employees

Sector

Investment Holding Companies

More about the company

23-11-03	Artemis Strategic Investment Corporation(NasdaqGM:ARTE) dropped from NASDAQ Composite Index	CI
23-10-25	Danam Health, Inc. cancelled the acquisition of Artemis Strategic Investment Corporation from Artemis Sponsor, LLC and others in a reverse merger transaction.	CI
23-09-19	Artemis Strategic Investment Files Registration Statement for Proposed Business Combination With Danam Health	MT
23-08-10	Artemis Strategic Investment Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
23-08-06	Danam Health, Inc. entered into a definitive agreement to acquire Artemis Strategic Investment Corporation in a reverse merger transaction.	CI
23-08-04	Artemis Strategic Investment Corporation Announces Executive Changes	CI
23-06-01	Novibet PLC cancelled the acquisition of Artemis Strategic Investment Corporation from a group of shareholders in a reverse merger transaction.	CI
23-04-27	Artemis Strategic Investment Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
23-03-31	Artemis Strategic Investment Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	CI
23-03-30	Artemis Strategic Investment Corporation Auditor Raises 'Going Concern' Doubt	CI
22-11-09	Artemis Strategic Investment Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI
22-07-21	Artemis Strategic Investment Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	CI
22-05-03	Artemis Strategic Investment Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	CI

23-06-20	ARTEMIS STRATEGIC INVESTMENT CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
23-06-09	ARTEMIS STRATEGIC INVESTMENT CORP : Termination of a Material Definitive Agreement (form 8-K)	AQ
23-04-27	ARTEMIS STRATEGIC INVESTMENT CORP Management's Discussion And Analysis Of Financial Condition And Results Of Operations (form 10-Q)	AQ
23-03-31	ARTEMIS STRATEGIC INVESTMENT CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	AQ
23-03-31	ARTEMIS STRATEGIC INVESTMENT CORP : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)	AQ

Manager	Title	Age	Since
Philip Kaplan CEO	Chief Executive Officer	59	-
Scott Shulak AUD	Comptroller/Controller/Auditor	39	-
Thomas Granite DFI	Director of Finance/CFO	50	-

Director	Title	Age	Since
Matthew Anfinson BRD	Director/Board Member	46	2021-03-18
Rodney A. Butler BRD	Director/Board Member	49	2021-03-18
Andro Nodarse-León BRD	Director/Board Member	48	2021-03-18

Date	Insider	Type	Main position	Quantity	% Market Cap.
7/6/23	Atlas Merchant Capital LLC	Other	Company	621,621	3.0888%
10/4/21	Artemis Sponsor LLC	Issuer sale	Company	1,618,434	32.1676%
9/29/21	Artemis Sponsor LLC	Other	Company	5,031,250	25.0000%

Artemis Strategic Investment Corporation Stock

Stocks

ARTE

US04303A1034

Investment Holding Companies

Latest news : Artemis Strategic Investment Corporation

Press Releases: Artemis Strategic Investment Corporation

Quotes and Performance

Managers and Directors: Artemis Strategic Investment Corporation

Latest insider transactions

Shell Companies

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ARTEMIS STRATEGIC INVESTMENT CORPORATION	+0.14%	-.--%	-	-	76.68M
CHURCHILL CAPITAL CORP XI	+3.55%	-14.65%	-	-	812M
CENTIEL AG	-7.45%	-7.18%	+311.46%	-70.90%	658M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	0.00%	+0.10%	-	-	646M
BAIN CAPITAL GSS INVESTMENT CORP.	-0.39%	+0.29%	-	-	600M
CHURCHILL CAPITAL CORP XII	-0.74%	-0.33%	-	-	595M
CANTOR EQUITY PARTNERS IV, INC.	-0.48%	-0.77%	+2.02%	-	591M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	+0.52%	+1.21%	-	-	578M
CHURCHILL CAPITAL CORP XIII	0.00%	+0.67%	-	-	508M
Average	-0.54%	-2.59%	+156.74%	-70.90%	623.41M
Weighted average by Cap.	-0.53%	-3.22%	+165.02%	-70.90%